Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
We investigated the metabolism of very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) apolipoprotein B (apoB) in seven patients with combined hyperlipidemia (CHL), using 125I-labeled VLDL and 131I-labeled LDL and compartmental modeling, befo...
Main Authors: | Y Arad, R Ramakrishnan, HN Ginsberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1990-04-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520428251 |
Similar Items
-
Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia
by: C. Verseyden, et al.
Published: (2002-02-01) -
Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia
by: J. Kovar, et al.
Published: (2002-07-01) -
Surface study of apoB1694–1880, a sequence that can anchor apoB to lipoproteins and make it nonexchangeable
by: Libo Wang, et al.
Published: (2009-07-01) -
Lipid transfer proteins in the assembly of apoB-containing lipoproteins
by: Alaa Sirwi, et al.
Published: (2018-01-01) -
Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
by: T Demant, et al.
Published: (1993-01-01)